Leukocyte depleted blood products 19 tables

Cellular blood components contain variable numbers of donor leukocytes. The transfusion of leukocytes accompanying erythrocyte and platelet transfusion may be associated with a variety of potentially harmful effects in the recipient. These adverse effects can largely be avoided by removing leukocyte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Basel [u.a.] Karger 1994
Schriftenreihe:Current studies in hematology and blood transfusion 60
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV009689529
003 DE-604
005 20121004
007 t|
008 940706s1994 xx d||| |||| 00||| eng d
016 7 |a 94146475X  |2 DE-101 
020 |a 3805558627  |9 3-8055-5862-7 
035 |a (OCoLC)30027351 
035 |a (DE-599)BVBBV009689529 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-19  |a DE-12  |a DE-355 
050 0 |a RM171.4 
082 0 |a 615/.39  |2 20 
084 |a YU 1800  |0 (DE-625)154189:12905  |2 rvk 
245 1 0 |a Leukocyte depleted blood products  |b 19 tables  |c vol. ed. T. A. Lane ... 
246 1 3 |a Leukocyte-depleted blood products 
264 1 |a Basel [u.a.]  |b Karger  |c 1994 
300 |a VIII, 150 S.  |b graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Current studies in hematology and blood transfusion  |v 60 
500 |a Literaturangaben 
520 3 |a Cellular blood components contain variable numbers of donor leukocytes. The transfusion of leukocytes accompanying erythrocyte and platelet transfusion may be associated with a variety of potentially harmful effects in the recipient. These adverse effects can largely be avoided by removing leukocytes from blood components to a sufficient degree 
520 |a This volume, written by leading authorities in the field, provides a timely and comprehensive collection of reviews on the preparation, quality assurance and clinical use of leukocyte-depleted blood products. The most recent information on the adverse effects of leukocytes following blood transfusion is presented, and the effectiveness of methods to prevent or minimize these events by leukocyte depletion is carefully evaluated 
520 |a Attention is also given to unresolved and controversial issues, such as quality control and cost-efficiency, bringing out the variety of opinions held on these subjects 
650 7 |a Bloedtransfusie  |2 gtt 
650 7 |a Leukocyten  |2 gtt 
650 4 |a Produits sanguins déleucocytés 
650 4 |a Blood Component Transfusion 
650 4 |a Leucocyte-poor blood products 
650 4 |a Leukocytes  |x immunology 
650 4 |a Lymphocyte Depletion 
650 0 7 |a Blut  |0 (DE-588)4007259-9  |2 gnd  |9 rswk-swf 
650 0 7 |a Leukapherese  |0 (DE-588)4238349-3  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Blut  |0 (DE-588)4007259-9  |D s 
689 0 1 |a Leukapherese  |0 (DE-588)4238349-3  |D s 
689 0 |5 DE-604 
689 1 0 |a Leukapherese  |0 (DE-588)4238349-3  |D s 
689 1 |5 DE-604 
700 1 |a Lane, Thomas A.  |e Sonstige  |4 oth 
830 0 |a Current studies in hematology and blood transfusion  |v 60  |w (DE-604)BV000019114  |9 60 
943 1 |a oai:aleph.bib-bvb.de:BVB01-006407654 

Datensatz im Suchindex

_version_ 1819238169448546304
any_adam_object
building Verbundindex
bvnumber BV009689529
callnumber-first R - Medicine
callnumber-label RM171
callnumber-raw RM171.4
callnumber-search RM171.4
callnumber-sort RM 3171.4
callnumber-subject RM - Therapeutics and Pharmacology
classification_rvk YU 1800
ctrlnum (OCoLC)30027351
(DE-599)BVBBV009689529
dewey-full 615/.39
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
dewey-raw 615/.39
dewey-search 615/.39
dewey-sort 3615 239
dewey-tens 610 - Medicine and health
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02776nam a2200565 cb4500</leader><controlfield tag="001">BV009689529</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20121004 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">940706s1994 xx d||| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">94146475X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805558627</subfield><subfield code="9">3-8055-5862-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30027351</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009689529</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM171.4</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.39</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YU 1800</subfield><subfield code="0">(DE-625)154189:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Leukocyte depleted blood products</subfield><subfield code="b">19 tables</subfield><subfield code="c">vol. ed. T. A. Lane ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Leukocyte-depleted blood products</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 150 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Current studies in hematology and blood transfusion</subfield><subfield code="v">60</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Cellular blood components contain variable numbers of donor leukocytes. The transfusion of leukocytes accompanying erythrocyte and platelet transfusion may be associated with a variety of potentially harmful effects in the recipient. These adverse effects can largely be avoided by removing leukocytes from blood components to a sufficient degree</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This volume, written by leading authorities in the field, provides a timely and comprehensive collection of reviews on the preparation, quality assurance and clinical use of leukocyte-depleted blood products. The most recent information on the adverse effects of leukocytes following blood transfusion is presented, and the effectiveness of methods to prevent or minimize these events by leukocyte depletion is carefully evaluated</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Attention is also given to unresolved and controversial issues, such as quality control and cost-efficiency, bringing out the variety of opinions held on these subjects</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bloedtransfusie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Leukocyten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Produits sanguins déleucocytés</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood Component Transfusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leucocyte-poor blood products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukocytes</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphocyte Depletion</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Blut</subfield><subfield code="0">(DE-588)4007259-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Leukapherese</subfield><subfield code="0">(DE-588)4238349-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Blut</subfield><subfield code="0">(DE-588)4007259-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Leukapherese</subfield><subfield code="0">(DE-588)4238349-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Leukapherese</subfield><subfield code="0">(DE-588)4238349-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lane, Thomas A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Current studies in hematology and blood transfusion</subfield><subfield code="v">60</subfield><subfield code="w">(DE-604)BV000019114</subfield><subfield code="9">60</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006407654</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV009689529
illustrated Illustrated
indexdate 2024-12-23T13:31:57Z
institution BVB
isbn 3805558627
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-006407654
oclc_num 30027351
open_access_boolean
owner DE-19
DE-BY-UBM
DE-12
DE-355
DE-BY-UBR
owner_facet DE-19
DE-BY-UBM
DE-12
DE-355
DE-BY-UBR
physical VIII, 150 S. graph. Darst.
publishDate 1994
publishDateSearch 1994
publishDateSort 1994
publisher Karger
record_format marc
series Current studies in hematology and blood transfusion
series2 Current studies in hematology and blood transfusion
spelling Leukocyte depleted blood products 19 tables vol. ed. T. A. Lane ...
Leukocyte-depleted blood products
Basel [u.a.] Karger 1994
VIII, 150 S. graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Current studies in hematology and blood transfusion 60
Literaturangaben
Cellular blood components contain variable numbers of donor leukocytes. The transfusion of leukocytes accompanying erythrocyte and platelet transfusion may be associated with a variety of potentially harmful effects in the recipient. These adverse effects can largely be avoided by removing leukocytes from blood components to a sufficient degree
This volume, written by leading authorities in the field, provides a timely and comprehensive collection of reviews on the preparation, quality assurance and clinical use of leukocyte-depleted blood products. The most recent information on the adverse effects of leukocytes following blood transfusion is presented, and the effectiveness of methods to prevent or minimize these events by leukocyte depletion is carefully evaluated
Attention is also given to unresolved and controversial issues, such as quality control and cost-efficiency, bringing out the variety of opinions held on these subjects
Bloedtransfusie gtt
Leukocyten gtt
Produits sanguins déleucocytés
Blood Component Transfusion
Leucocyte-poor blood products
Leukocytes immunology
Lymphocyte Depletion
Blut (DE-588)4007259-9 gnd rswk-swf
Leukapherese (DE-588)4238349-3 gnd rswk-swf
(DE-588)4143413-4 Aufsatzsammlung gnd-content
Blut (DE-588)4007259-9 s
Leukapherese (DE-588)4238349-3 s
DE-604
Lane, Thomas A. Sonstige oth
Current studies in hematology and blood transfusion 60 (DE-604)BV000019114 60
spellingShingle Leukocyte depleted blood products 19 tables
Current studies in hematology and blood transfusion
Bloedtransfusie gtt
Leukocyten gtt
Produits sanguins déleucocytés
Blood Component Transfusion
Leucocyte-poor blood products
Leukocytes immunology
Lymphocyte Depletion
Blut (DE-588)4007259-9 gnd
Leukapherese (DE-588)4238349-3 gnd
subject_GND (DE-588)4007259-9
(DE-588)4238349-3
(DE-588)4143413-4
title Leukocyte depleted blood products 19 tables
title_alt Leukocyte-depleted blood products
title_auth Leukocyte depleted blood products 19 tables
title_exact_search Leukocyte depleted blood products 19 tables
title_full Leukocyte depleted blood products 19 tables vol. ed. T. A. Lane ...
title_fullStr Leukocyte depleted blood products 19 tables vol. ed. T. A. Lane ...
title_full_unstemmed Leukocyte depleted blood products 19 tables vol. ed. T. A. Lane ...
title_short Leukocyte depleted blood products
title_sort leukocyte depleted blood products 19 tables
title_sub 19 tables
topic Bloedtransfusie gtt
Leukocyten gtt
Produits sanguins déleucocytés
Blood Component Transfusion
Leucocyte-poor blood products
Leukocytes immunology
Lymphocyte Depletion
Blut (DE-588)4007259-9 gnd
Leukapherese (DE-588)4238349-3 gnd
topic_facet Bloedtransfusie
Leukocyten
Produits sanguins déleucocytés
Blood Component Transfusion
Leucocyte-poor blood products
Leukocytes immunology
Lymphocyte Depletion
Blut
Leukapherese
Aufsatzsammlung
volume_link (DE-604)BV000019114
work_keys_str_mv AT lanethomasa leukocytedepletedbloodproducts19tables
AT lanethomasa leukocytedepletedbloodproducts